Avidity Biosciences Inc (RNA)

Jan 29, 2025

We're Hopeful That Avidity Biosciences (NASDAQ:RNA) Will Use Its Cash Wisely - Yahoo Finance

Jan 29, 2025

Jan 28, 2025

How to Take Advantage of moves in (RNA) - Stock Traders Daily

Jan 28, 2025

Jan 27, 2025

Avidity Biosciences (NASDAQ:RNA) Stock Price Up 6%Here's Why - MarketBeat

Jan 27, 2025

Jan 27, 2025

Avidity Biosciences, Inc. (NASDAQ:RNA) Receives Consensus Recommendation of "Buy" from Analysts - MarketBeat

Jan 27, 2025

Jan 25, 2025

Avidity Biosciences CEO Sarah Boyce sells $297k in stock - MSN

Jan 25, 2025

Jan 25, 2025

Avidity Biosciences' chief medical officer sells shares totaling $112,856 - MSN

Jan 25, 2025

Jan 25, 2025

Assenagon Asset Management S.A. Invests $1.18 Million in Avidity Biosciences, Inc. (NASDAQ:RNA) - MarketBeat

Jan 25, 2025

Jan 24, 2025

Avidity Biosciences CHRO Teresa McCarthy sells $84,611 in stock - MSN

Jan 24, 2025

Jan 24, 2025

Avidity Biosciences chief scientific officer sells shares worth $162,191 - MSN

Jan 24, 2025

Jan 24, 2025

Avidity Biosciences director sells $53,536 in stock - MSN

Jan 24, 2025

Jan 24, 2025

Avidity Biosciences, Inc. (NASDAQ:RNA) CFO Michael F. Maclean Sells 3,287 Shares - MarketBeat

Jan 24, 2025

Jan 24, 2025

Insider Selling: Avidity Biosciences, Inc. (NASDAQ:RNA) Insider Sells 2,959 Shares of Stock - MarketBeat

Jan 24, 2025

Jan 24, 2025

Sarah Boyce Sells 10,397 Shares of Avidity Biosciences, Inc. (NASDAQ:RNA) Stock - MarketBeat

Jan 24, 2025

Jan 24, 2025

Avidity Biosciences CHRO Teresa McCarthy sells $84,611 in stock By Investing.com - Investing.com Canada

Jan 24, 2025

Jan 24, 2025

Arthur A. Levin Sells 1,872 Shares of Avidity Biosciences, Inc. (NASDAQ:RNA) Stock - MarketBeat

Jan 24, 2025

Jan 23, 2025

Avidity Biosciences director sells $53,536 in stock By Investing.com - Investing.com Canada

Jan 23, 2025

Jan 23, 2025

Avidity Biosciences CFO sells $93,985 in stock By Investing.com - Investing.com Canada

Jan 23, 2025

Jan 23, 2025

Avidity Biosciences chief program officer sells shares worth $206,799 By Investing.com - Investing.com Canada

Jan 23, 2025

Jan 23, 2025

Avidity Biosciences' chief medical officer sells shares totaling $112,856 By Investing.com - Investing.com Australia

Jan 23, 2025

Jan 23, 2025

Avidity Biosciences chief program officer sells shares worth $206,799 - Investing.com

Jan 23, 2025

Jan 23, 2025

Avidity Biosciences CEO Sarah Boyce sells $297k in stock By Investing.com - Investing.com UK

Jan 23, 2025

Jan 22, 2025

Analysts Offer Predictions for RNA FY2025 Earnings - MarketBeat

Jan 22, 2025

Jan 22, 2025

Leerink Partnrs Has Negative Estimate for RNA Q1 Earnings - MarketBeat

Jan 22, 2025

Jan 21, 2025

Royal Bank of Canada Reiterates Outperform Rating for Avidity Biosciences (NASDAQ:RNA) - MarketBeat

Jan 21, 2025

Jan 20, 2025

Avidity Biosciences Announces Inducement Grants Under Nasdaq Lis - GuruFocus.com

Jan 20, 2025

Jan 20, 2025

Exciting News from Avidity Biosciences! New Opportunities Await! - Qhubo

Jan 20, 2025

Jan 20, 2025

Avidity Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - StreetInsider.com

Jan 20, 2025

Jan 20, 2025

Avidity Biosciences Awards New Employee Stock Options and RSUs Worth $304K - StockTitan

Jan 20, 2025

Jan 17, 2025

12 Biotech Stocks with the Biggest Upside Potential - Insider Monkey

Jan 17, 2025

Jan 17, 2025

Avidity Biosciences, Inc. (RNA): The Biotech Stock with Biggest Upside Potential - Insider Monkey

Jan 17, 2025

Jan 15, 2025

Avidity Set To File First Of Three Muscular Dystrophy Drugs In 2025 - News & Insights

Jan 15, 2025

Jan 14, 2025

Avidity Biosciences Inc (RNA-Q) QuotePress Release - The Globe and Mail

Jan 14, 2025

Jan 13, 2025

Avidity Biosciences Becomes Oversold (RNA) - Nasdaq

Jan 13, 2025

Jan 10, 2025

Avidity Biosciences (NASDAQ:RNA) Sees Large Volume IncreaseHere's Why - MarketBeat

Jan 10, 2025

Jan 10, 2025

Avidity Biosciences (NASDAQ:RNA) Given Buy Rating at HC Wainwright - MarketBeat

Jan 10, 2025

Jan 10, 2025

Analyst Expectations For Avidity Biosciences's Future - Benzinga

Jan 10, 2025

Jan 09, 2025

JPMorgan Chase & Co. Has $21.45 Million Stock Holdings in Avidity Biosciences, Inc. (NASDAQ:RNA) - Defense World

Jan 09, 2025

Jan 08, 2025

Avidity Biosciences, Inc. Announces 2025 Upcoming Clinical and Regulatory Highlights - Marketscreener.com

Jan 08, 2025

Jan 08, 2025

Avidity Biosciences Plans First BLA Submission and Accelerates Commercialization Preparations for Three Rare Muscle Disease Programs in 2025 - PR Newswire

Jan 08, 2025

Jan 08, 2025

Avidity Biosciences Awards $31.42 Stock Options to New Chief Technical Officer - StockTitan

Jan 08, 2025

Jan 06, 2025

Principal Financial Group Inc. Reduces Holdings in Avidity Biosciences, Inc. (NASDAQ:RNA) - Defense World

Jan 06, 2025

Jan 02, 2025

Avidity Biosciences, Inc. (NASDAQ:RNA) Receives $64.36 Average Target Price from Analysts - MarketBeat

Jan 02, 2025

Jan 01, 2025

Why Is Avidity Biosciences, Inc. (RNA) Among the Best Multibagger Stocks to Buy Right Now? - Insider Monkey

Jan 01, 2025

Jan 01, 2025

Companies Like Avidity Biosciences (NASDAQ:RNA) Are In A Position To Invest In Growth - Simply Wall St

Jan 01, 2025

Dec 31, 2024

12 Best Multibagger Stocks to Buy Right Now - Insider Monkey

Dec 31, 2024

Dec 30, 2024

Avidity Biosciences (NASDAQ:RNA) Trading Down 5.4%What's Next? - MarketBeat

Dec 30, 2024